BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The company’s smartphone-based application serves as a device for conducting neurobehavioral evaluations. Its application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Sydney, Australia.
Australian Market Performance
7D7 Days: 0.2%
3M3 Months: 7.6%
1Y1 Year: 8.9%
YTDYear to Date: 5.7%
The market has been flat over the last week. As for the longer term, the market has risen 8.9% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...